Chemical Structure Formula Of Budesonide (Budesonide Inhalation Suspension 1)
Budesonide Inhalation Suspension
Product Images NDC 0115-1687
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Budesonide Inhalation (NDC 0115-1687). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Amneal Pharmaceuticals Of New York Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1: A 12-week Trial In Pediatric Patients Previously Maintained On Inhaled Corticosteroid Therapy Prior To Study Entry. Nighttime Asthma Change From Baseline (Budesonide Inhalation Suspension 2)
This is a chart showing the mean change from baseline in nighttime asthma symptoms over a 12-week period. The chart includes data for a placebo group and two treatment groups, one taking 0.25 mg of medication twice daily and the other taking 0.5 mg twice daily. The chart presents data for specific time periods within the 12-week timeframe, including Week 0-2, Week 2-4, Week 4-6, Week 6-8, Week 8-10, and Week 10-12.*
Figure 2: A 12-week Trial In Pediatric Patients Either Maintained On Bronchodilators Alone Or Inhaled Corticosteroid Therapy Prior To Study Entry. Nighttime Asthma Change From Baseline (Budesonide Inhalation Suspension 3)
This appears to be a section of a chart or graph related to a study on asthma symptoms at night over the course of 12 weeks. The chart shows different time periods and treatment groups (placebo, 0.25mg twice daily, and 0.5mg twice daily). The main focus seems to be on the weaning of a medication called "Uhange" in relation to baseline symptoms. However, without further context or information, the purpose and findings of the study cannot be fully determined.*
Figure 1 Open The Sealed Foil Envelope Along The Dotted Line And Take Out 1 Single-dose Ampule From The Strip. (Budesonide Inhalation Suspension 4)
Figure 2 Gently Shake The Budesonide Inhalation Suspension Ampule Using A Circular Motion (Budesonide Inhalation Suspension 5)
Figure 3 Hold The Budesonide Inhalation Suspension Ampule Upright Without Squeezing The Ampule And Open By Twisting Off The Top. (Budesonide Inhalation Suspension 6)
4. Place The Open End Of The Budesonide Inhalation Suspension Ampule Into The Nebulizer Cup (reservoir) And Slowly Squeeze All Of The Medicine From The Ampule Into The Nebulizer Medicine Cup As Shown In Figure 4. Throw Away The Empty Ampule. (Budesonide Inhalation Suspension 7)
0.25 mg/2 mL Budesonide (Budesonide Inhalation Suspension 8)
This is a prescription medicine called Budesonide Inhalation Suspension. The instructions on how to use this medication are included. It comes in a box that contains 30 small vials (ampules) and is intended for inhalation. No other information is available as the text is incomplete and not readable.*
0.5 mg/2ml Budesonide (Budesonide Inhalation Suspension 9)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
